Source: Eur Respir J, 58 (3) 2100304; 10.1183/13993003.00304-2021
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Job F.M. van Boven, Boudewijn J.H. Dierick, Omar S. Usmani. When biology meets behaviour: can medication adherence mask the contribution of pharmacogenetic effects in asthma?. Eur Respir J, 58 (3) 2100304; 10.1183/13993003.00304-2021

Member's Comments

No comment yet.

Related content which might interest you: Understanding patient’ adherence to inhaled medication: the social representations of COPD Source: International Congress 2017 – COPD management Year: 2017 What matters to people with severe asthma? Exploring add-on asthma medication and outcomes of importance Source: ERJ Open Res, 7 (1) 00497-2020; 10.1183/23120541.00497-2020 Year: 2021 Measuring airway hyperresponsiveness: does it add to routine measures of clinical efficacy in guiding asthma therapy? Source: Eur Respir J 2006; 28: Suppl. 50, 319s Year: 2006 SABINA: global programme to evaluate prescriptions and clinical outcomes related to short-acting ß2-agonist use in asthma Source: Eur Respir J, 55 (2) 1901858; 10.1183/13993003.01858-2019 Year: 2020 Do general practitioners use effective communication for discussing patients‘ adherence with asthma medications? Source: Annual Congress 2012 - Effectiveness of therapeutic interventions in primary care Year: 2012 Evaluating the effects of asthma therapy on childhood growth: principles of study design Source: Eur Respir J 2002; 19: 1167-1178 Year: 2002 Is there evidence showing that real-life aspects (comorbid conditions, inhaler technique, and lifetstyle factors) influence asthma management? Source: International Congress 2014 – The evolving role of real-life research in respiratory medicine Year: 2014 Assessing the effect of medical therapy in COPD: from pathophysiology and biomarkers to clinical practice Source: Annual Congress 2009 - PG15 The complexity of COPD: assessment and advanced therapies Year: 2009 Adherence to asthma treatment: Can it be improved in general practice? Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management Year: 2012 Physician‘s perception of pediatric asthma control is influenced by the use of medication Source: Eur Respir J 2003; 22: Suppl. 45, 365s Year: 2003 Does combination therapy lead to better adherence in asthma? Source: Annual Congress 2010 - Combination therapy in asthma and COPD Year: 2010 Development and evaluation of an educational intervention targeted at optimising adherence with measures to prevent asthma in children with a familial allergic disposition (FOCUS-project) Source: Eur Respir J 2002; 20: Suppl. 38, 329s Year: 2002 Evaluating the effects of asthma therapy on childhood growth: what can be learnt from the published literature? Source: Eur Respir J 2002; 19: 1179-1193 Year: 2002 Daily pattern of ß2-agonists: understanding real-life use of rescue medication Source: International Congress 2017 – Asthma management Year: 2017 The paradoxes of asthma management: time for a new approach? Source: Eur Respir J, 50 (3) 1701103; 10.1183/13993003.01103-2017 Year: 2017 High inhaled corticosteroids adherence in childhood asthma: the role of medication beliefs Source: Eur Respir J 2012; 40: 1149-1155 Year: 2012 The patient’s role in the choice of new inhaler devices and dosing regimens for asthma and COPD: A preference study Source: International Congress 2016 – Kaleidoscope of respiratory nursing Year: 2016 Modelling and simulation in successful drug development programmes: Characterisation of exacerbation reduction with roflumilast to corroborate the importance of defining patient subsets in COPD Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011